Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2016 Feb 22;14(7):973–979. doi: 10.1016/j.cgh.2016.02.017

Table 3.

Characteristics of colorectal cancer in statin users and non-users

Characteristic Statin users (n = 30) Statin non-users (n = 287) p-value
Age at cancer diagnosis [Median(IQR)] (in years) 67 (63 – 73) 55 (45 – 65) < 0.001
Age at first IBD contact [Median(IQR)] (in years) 64 (56 – 68) 53 (41 – 64) < 0.001
Mean duration since first IBD contact (in years) 6 3 < 0.001
Female (%) 33 42 0.35
White (%) 93 89 0.48
Ulcerative colitis (%) 80 46 < 0.001
Co-existing PSC (%) 7 5 0.67
Medical therapies
Immunomodulator (%) 23 16 0.31
Anti-TNF biologics (%) 0 7 0.14
C-Reactive protein [Median(IQR)] (in mg/L) 5.4 (0.5 – 11.8) 7.1 (3.7 – 29.4) < 0.001
Ever smoker (%) 93 71 0.008
Died (%) 30 27 0.74